UniProtKB/Swiss-Prot P11532: Variant p.Gln133Pro

Dystrophin
Gene: DMD
Feedback?

Variant information Variant position:

133 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Glutamine (Q) to Proline (P) at position 133 (Q133P, p.Gln133Pro). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and polar (Q) to medium size and hydrophobic (P) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs1800256 [ dbSNP | Ensembl ]

Sequence information Variant position:

133 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

3685 The length of the canonical sequence.
Location on the sequence:

NIILHWQVKNVMKNIMAGLQ Q TNSEKILLSWVRQSTRNYPQ The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         NII-LHWQVKNVMKNIMAGLQQTNSEKILLSWVRQSTRNYPQ

                              NII-LHWQVKNVMKNIMAGLQQTNSEKILLSWVRQSTRNYP

Mouse                         NII-LHWQVKNVMKTIMAGLQQTNSEKILLSWVRQSTRNYP

Rat                           NII-LHWQVKNVMKTIMAGLQQTNSEKILLSWVRESTRNYP

Pig                           NII-LHWQVKNVMKNIMAGLQQTNSEKILLSWVRQSTRNYP

Chicken                       NII-LHWQVKDVMKNIMAGLQQTNSEKILLSWVRQSTRNYP

Caenorhabditis elegans        QLVQFFWK-----NNAPVQLREEKLSEAIKQWCIEVMKSYE

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 3685	Dystrophin
Region	1 – 240	Actin-binding
Alternative sequence	1 – 3068	Missing. In isoform 12, isoform 13, isoform 14, isoform 15, isoform 16 and isoform 17.
Alternative sequence	1 – 2729	Missing. In isoform 11.
Alternative sequence	1 – 2460	Missing. In isoform 6, isoform 7, isoform 8, isoform 9 and isoform 10.
Alternative sequence	2 – 1357	Missing. In isoform 4 and isoform 5.

Literature citations
Two human cDNA molecules coding for the Duchenne muscular dystrophy (DMD) locus are highly homologous.
Rosenthal A.; Speer A.; Billowitz H.; Cross G.S.; Forrest S.N.; Davies K.E.;
Nucleic Acids Res. 17:5391-5391(1989)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANTS PRO-133; ILE-623; GLY-784; GLY-882; PHE-1197; ASN-1377; HIS-1745; SER-1844 AND GLN-2937;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.